| Protein PEGylation for cancer therapy: bench to bedside V Gupta, S Bhavanasi, M Quadir, K Singh, G Ghosh, K Vasamreddy, ... Journal of Cell Communication and Signaling 13, 319-330, 2019 | 129 | 2019 |
| Leptin-induced ER-£\-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway I Haque, A Ghosh, S Acup, S Banerjee, K Dhar, A Ray, S Sarkar, ... BMC cancer 18, 1-14, 2018 | 69 | 2018 |
| The MAZ transcription factor is a downstream target of the oncoprotein Cyr61/CCN1 and promotes pancreatic cancer cell invasion via CRAF¡VERK signaling G Maity, I Haque, A Ghosh, G Dhar, V Gupta, S Sarkar, I Azeem, ... Journal of Biological Chemistry 293 (12), 4334-4349, 2018 | 49 | 2018 |
| Size-transformable, multifunctional nanoparticles from hyperbranched polymers for environment-specific therapeutic delivery P Ray, L Alhalhooly, A Ghosh, Y Choi, S Banerjee, S Mallik, S Banerjee, ... ACS Biomaterials Science & Engineering 5 (3), 1354-1365, 2019 | 46 | 2019 |
| CCN5 activation by free or encapsulated EGCG is required to render triple‐negative breast cancer cell viability and tumor progression A Das, I Haque, P Ray, A Ghosh, D Dutta, M Quadir, A De, ... Pharmacology research & perspectives 9 (2), e00753, 2021 | 35 | 2021 |
| MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis A Ghosh, S Sarkar, S Banerjee, F Behbod, O Tawfik, D McGregor, S Graff, ... PloS one 13 (5), e0198143, 2018 | 35 | 2018 |
| Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth A Das, K Dhar, G Maity, S Sarkar, A Ghosh, I Haque, G Dhar, S Banerjee, ... Scientific reports 7 (1), 1220, 2017 | 34 | 2017 |
| Microenvironment-sensing, nanocarrier-mediated delivery of combination chemotherapy for pancreatic cancer P Ray, G Nair, A Ghosh, S Banerjee, MY Golovko, SK Banerjee, ... Journal of cell communication and signaling 13, 407-420, 2019 | 33 | 2019 |
| CYR61/CCN1 regulates dCK and CTGF and causes gemcitabine-resistant phenotype in pancreatic ductal adenocarcinoma G Maity, A Ghosh, V Gupta, I Haque, S Sarkar, A Das, K Dhar, ... Molecular cancer therapeutics 18 (4), 788-800, 2019 | 33 | 2019 |
| A study of the expression and localization of toll-like receptors 2 and 9 in different grades of cervical intraepithelial neoplasia and squamous cell carcinoma A Ghosh, A Dasgupta, A Bandyopadhyay, TK Ghosh, R Dalui, S Biswas, ... Experimental and molecular pathology 99 (3), 720-724, 2015 | 27 | 2015 |
| CCN5/WISP-2 restores ER-∝ in normal and neoplastic breast cells and sensitizes triple negative breast cancer cells to tamoxifen S Sarkar, A Ghosh, S Banerjee, G Maity, A Das, MA Larson, V Gupta, ... Oncogenesis 6 (5), e340, 2017 | 26 | 2017 |
| Exosomes in carcinogenesis: molecular palkis carry signals for the regulation of cancer progression and metastasis A Subramanian, V Gupta, S Sarkar, G Maity, S Banerjee, A Ghosh, ... Journal of cell communication and signaling 10 (3), 241, 2016 | 25 | 2016 |
| Aspirin suppresses tumor cell-induced angiogenesis and their incongruity G Maity, J Chakraborty, A Ghosh, I Haque, S Banerjee, SK Banerjee Journal of cell communication and signaling 13, 491-502, 2019 | 22 | 2019 |
| The miRacle in pancreatic cancer by miRNAs: tiny angels or devils in disease progression Z Hawa, I Haque, A Ghosh, S Banerjee, LC Harris, SK Banerjee International Journal of Molecular Sciences 17 (6), 809, 2016 | 22 | 2016 |
| Expression of matrix metalloproteinase-2 and 9 in cervical intraepithelial neoplasia and cervical carcinoma among different age groups of premenopausal and postmenopausal women A Ghosh, A Moirangthem, R Dalui, TK Ghosh, A Bandyopadhyay, ... Journal of cancer research and clinical oncology 140, 1585-1593, 2014 | 21 | 2014 |
| Human pancreatic cancer progression: an anarchy among CCN-siblings SK Banerjee, G Maity, I Haque, A Ghosh, S Sarkar, V Gupta, ... Journal of cell communication and signaling 10 (3), 207, 2016 | 19 | 2016 |
| Evaluation of the durability of the immune humoral response to COVID-19 vaccines in patients with cancer undergoing treatment or who received a stem cell transplant QJ Khan, CR Bivona, GA Martin, J Zhang, B Liu, J He, KH Li, M Nelson, ... JAMA oncology 8 (7), 1053-1058, 2022 | 18 | 2022 |
| Zoledronic acid-induced suppression of invasive phenotypes of pancreatic cancer cells is mediated through downregulation of CYR61/CCN1 A Ghosh, S Sarkar, S Ghosh, P Ray, M Quadir, SK Banerjee, S Banerjee Cancer research 79 (13_Supplement), 1234-1234, 2019 | 12 | 2019 |
| Cyr61/CCN1 targets for chemosensitization in pancreatic cancer S Banerjee, A Ghosh, DD VonHoff, SK Banerjee Oncotarget 10 (38), 3579, 2019 | 12 | 2019 |
| Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients QJ Khan, CR Bivona, B Liu, M Nelson, GA Martin, MU Mushtaq, P Sharma, ... Bone Marrow Transplantation 57 (6), 1013-1016, 2022 | 4 | 2022 |
Inamul HaqueAssistant Professor, University of Kansas Medical Center, Kansas City, KS and Research Biologist, VAVerified email at kumc.edu
